(Q36903745)

English

Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris

scientific article published on January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

based on heuristic

inferred from title

Dean M Robinson

object named as

Dean M Robinson

4

0 references

author name string

Caroline Fenton

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Keri Wellington

2

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Marit D Moen

3

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

67

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1749-1765

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Premenstrual Dysphoric Disorder: Recognition and Treatment

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767120-00007

21 January 2018

Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767120-00007

21 January 2018

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767120-00007

21 January 2018

A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shorter pill-free interval in combined oral contraceptives decreases follicular development

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOGC clinical practice guidelines: Canadian contraception consensus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acne: effect of hormones on pathogenesis and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yasmin--a new oral contraceptive, a new progestogen: the reasons why.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Added benefits of drospirenone for compliance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily Record of Severity of Problems (DRSP): reliability and validity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noncontraceptive health benefits of combined oral contraception

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current views on the aetiology, pathogenesis and treatment of acne vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of a new oral contraceptive containing drospirenone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current concepts of the pathogenesis of acne: implications for drug treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral contraceptives: an update on health benefits and risks.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FFPRHC Guidance (October 2003): First prescription of combined oral contraception

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone withdrawal symptoms in oral contraceptive users

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of contraception and use of family planning services in the United States: 1982-2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premenstrual dysphoric disorder: a review for the treating practitioner.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17683173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200767120-00007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36903745&oldid=2199537096"